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Administration of prostaglandin to beef heifers at time of artificial insemination
Abstract
Transportation of sperm is a critical component of reproductive success. Another factor in reproductive
success are the contractions of the uterine myometrium, which influence the number of sperm that reach
the oviduct. prostaglandin F2α(PG) is present in bull semen and has a variety of functions in reproduction,
including stimulating myometrial contractions. Evidence of improved fertility after administration of PG at
breeding has been shown in the rabbit, sow, and cow. An injection of PG at the time of insemination
improved conception rates in heifers inseminated with semen with only 30% motility. The objective of the
study was to determine if administration of prostaglandin F2αat the time of insemination would improve
pregnancy rate to artificial insemination (AI) when insemination occurred after observed estrus or at
fixed-time insemination.
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Administration of Prostaglandin to Beef Heifers
at Time of Artificial Insemination
S.K. Johnson and J.R. Jaeger

Introduction

Transportation of sperm is a critical component of reproductive success. Another
factor in reproductive success are the contractions of the uterine myometrium, which
influence the number of sperm that reach the oviduct. Prostaglandin F2α (PG) is present in bull semen and has a variety of functions in reproduction, including stimulating
myometrial contractions. Evidence of improved fertility after administration of PG at
breeding has been shown in the rabbit, sow, and cow. An injection of PG at the time
of insemination improved conception rates in heifers inseminated with semen with
only 30% motility. The objective of the study was to determine if administration of
prostaglandin F2α at the time of insemination would improve pregnancy rate to artificial
insemination (AI) when insemination occurred after observed estrus or at fixed-time
insemination.

Experimental Procedures

Angus and Angus cross yearling heifers (n = 268) at a single location were assigned
randomly to AI either after observed estrus or at a fixed time. To synchronize estrus, all
heifers received a standard melengesterol acetate (MGA)–PG protocol of 0.5 mg/head
per day of MGA (Pfizer Animal Health, Whitehouse Station, NJ/Zoetis Florham Park,
NJ) for 14 days and 5 mL Prostamate (PG, IVX Animal Health, St. Joseph, MO/Bayer,
Shawnee Mission, KS), either 18.5 (n = 117; fixed-time AI) or 19 (n = 151; observed
estrus AI) days after the last feeding of MGA (Figure 1). Experienced technicians
inseminated heifers in the observed estrus AI group 6 to 12 hours after detected estrus.
Sixty hours after the Prostamate injection, heifers in the fixed-time AI group received
2 mL OvaCyst (gonadotropin-releasing hormone, IVX Animal Health/Bayer) and
were inseminated. At the time of insemination, every other heifer received 2 mL Estrumate (PG, Intervet-Shering Plough, Millsboro, DE/Merck, Summit, NJ). Seven sires
were used and were balanced across treatments. Pregnancy rate to AI was determined
via ultrasonography 42 days after AI.

Results and Discussion

Reproductive tract scores, measured 45 to 60 days prior to breeding in a subset of 166
heifers (Table 1) indicated heifers met standard recommendations of 50% or more with
tract scores of 3 or greater prior to breeding. The average interval between PG injections
on day 18.5 to fixed-time AI was 62.2 ± 1.1 hours. Pregnancy rate to AI (P < 0.06)
tended to be higher in heifers inseminated after observed estrus (57%) than timed-AI
(46%). The interaction of insemination type with PG treatment at AI tended to be
significant (P < 0.08). Pregnancy rate to AI was lowest in fixed-timed AI heifers that
did not receive PG at insemination (Figure 2). The incidence of standing estrus was not
recorded for heifers in the fixed-timed AI group. Sperm transport may be improved in
fixed-time AI heifers treated with PG that were not in heat at the time of insemination.
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Further research is needed to clarify if administration of PGF2α at the time of insemination may improve conception to fixed-time AI.

Implications

This study provides evidence that insemination after observed estrus tends to produce
more AI pregnancies than fixed-timed AI at 60 hours after PG in the MGA-PG protocol. The study also shows that additional research is needed to determine the potential
benefit of PGF2α at fixed-timed AI.
Table 1. Distribution of reproductive tract scores in yearling heifers
Reproductive tract score1
1
2
3
4
Proportion of heifers, %
0.6
41
47.6
10.8
1

5
0

1 = infantile; 5 = mature tract and corpus luteum.

MGA-PG: AI after estrus
PG
MGA
1

19 days
14

Treatment day

39

33
Heat detect and AI ± PG
± PG
+ GnRH
+ AI

MGA-PG: Single fixed-time AI
PG
MGA
1

60 hours

18.5 days
14

Treatment day

32.5

35

Figure 1. Diagram of treatments for synchronization of estrus and time of artificial
insemination (AI). MGA = melengesterol acetate (Pfizer Animal Health, Whitehouse
Station, NJ); PG = prostaglandin F2α, Prostamate (IVX Animal Health, St. Joseph, MO)
day 32–33 and Estrumate (Intervet-Schering Plough, Millsboro, DE) after day 33; GnRH =
gonadotropin-releasing hormone (OvaCyst, IVX Animal Health, St Joseph, MO).
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Figure 2. Pregnancy rate for heifers inseminated after observed estrus or at a single fixedtime artificial insemination (AI) that did or did not receive prostaglandin F2α (PG) at time
of insemination. Insemination type × prostaglandin F2α treatment, P < 0.08.
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